$6.69
-0.42-5.91%
At close: May 14, 5:00 PM EST
$6.70
-0.41-5.77%
Pre-Market: 5:49 AM EST
Fulcrum Therapeutics Inc Earnings Estimates
FULCNASDAQ
Fulcrum Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FULC
Fulcrum Therapeutics (FULC) is scheduled to report Q2 earnings on July 28, 2026. Analysts estimate EPS of $-0.28 and quarterly revenue of N/A.
In the most recent quarter (Q1), Fulcrum Therapeutics reported EPS of $-0.25, beating estimates of $-0.30 by 0.17%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Fulcrum Therapeutics has averaged an EPS surprise of 0.07% and a revenue surprise of 0.00%.
Earnings Date
Jul 28
EPS Estimate
$-0.280
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Fulcrum Therapeutics Earnings History
Analyze the earnings history of Fulcrum Therapeutics using advanced sorting and filters.
Loading calendar...
Fulcrum Therapeutics (FULC) Earnings Per Share
The chart below shows Fulcrum Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Fulcrum Therapeutics (FULC) Revenue
The chart below shows Fulcrum Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics (FULC) is scheduled to report earnings on July 28, 2026. The last reported earnings were for reported on April 27, 2026 for Q1.
What were the latest earnings per share (EPS) for Fulcrum Therapeutics (NASDAQ:FULC)?
The Actual EPS was $-0.25, which beat the estimate of $-0.30.
What were Fulcrum Therapeutics’s (NASDAQ:FULC) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
